Related references
Note: Only part of the references are listed.Specific effects of somatic GATA2 zinc finger mutations on erythroid differentiation
Georg Leubolt et al.
EXPERIMENTAL HEMATOLOGY (2022)
Mitochondrial metabolism as a potential therapeutic target in myeloid leukaemia
Lucie de Beauchamp et al.
LEUKEMIA (2022)
Expanding the Reach of Precision Oncology by Drugging All KRAS Mutants
Marco H. Hofmann et al.
CANCER DISCOVERY (2022)
Comparative Gene Expression Analysis Reveals Similarities and Differences of Chronic Myeloid Leukemia Phases
Annemarie Schwarz et al.
CANCERS (2022)
BI-3406, a Potent and Selective SOS1-KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers through Combined MEK Inhibition
Marco H. Hofmann et al.
CANCER DISCOVERY (2021)
Combating TKI resistance in CML by inhibiting the PI3K/Akt/mTOR pathway in combination with TKIs: a review
Priyanka Singh et al.
MEDICAL ONCOLOGY (2021)
Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?
Bilal Abdulmawjood et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Integrated cross-study datasets of genetic dependencies in cancer
Clare Pacini et al.
NATURE COMMUNICATIONS (2021)
Chronic myeloid leukemia stem cells: targeting therapeutic implications
Hanieh Mojtahedi et al.
STEM CELL RESEARCH & THERAPY (2021)
Targeting SOS1 overcomes imatinib resistance with BCR-ABL independence through uptake transporter SLC22A4 in CML
Yanjun Liu et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Functional Specificity of the Members of the Sos Family of Ras-GEF Activators: Novel Role of Sos2 in Control of Epidermal Stem Cell Homeostasis
Fernando C. Baltanas et al.
CANCERS (2021)
Targeting Leukemic Stem Cells in Chronic Myeloid Leukemia: Is It Worth the Effort?
Simona Soverini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Critical requirement of SOS1 RAS-GEF function for mitochondrial dynamics, metabolism, and redox homeostasis
Rosula Garcia-Navas et al.
ONCOGENE (2021)
Anthraquinones as Inhibitors of SOS RAS-GEF Activity
Alberto Fernandez-Medarde et al.
BIOMOLECULES (2021)
Response and Resistance to BCR-ABL1-Targeted Therapies
Theodore P. Braun et al.
CANCER CELL (2020)
SOS GEFs in health and disease
Fernando C. Baltanas et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
BI-3406 and BI 1701963: Potent and selective SOS1::KRAS inhibitors induce regressions in combination with MEK inhibitors or irinotecan
Daniel Gerlach et al.
CANCER RESEARCH (2020)
Frontline Science: TNF-α and GM-CSF1 priming augments the role of SOS1/2 in driving activation of Ras, PI3K-γ, and neutrophil proinflammatory responses
Sabine Suire et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS-SOS1 interaction
Roman C. Hillig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Chronic myelogenous leukemia, a still unsolved problem: pitfalls and new therapeutic possibilities
Sylwia Flis et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
A mechanism for increased sensitivity of acute myeloid leukemia to mitotoxic drugs
Svetlana B. Panina et al.
CELL DEATH & DISEASE (2019)
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
Jude Canon et al.
NATURE (2019)
The CSN3 subunit of the COP9 signalosome interacts with the HD region of Sos1 regulating stability of this GEF protein
Natasha Zarich et al.
ONCOGENESIS (2019)
Phosphorylation of SOS1 on tyrosine 1196 promotes its RAC GEF activity and contributes to BCR-ABL leukemogenesis
S. Gerboth et al.
LEUKEMIA (2018)
Differential Role of the RasGEFs Sos1 and Sos2 in Mouse Skin Homeostasis and Carcinogenesis
Pilar Liceras-Boillos et al.
MOLECULAR AND CELLULAR BIOLOGY (2018)
Unique dependence on Sos1 in Kras(G12D)-induced leukemogenesis
Xiaona You et al.
BLOOD (2018)
The RAS-ERK pathway: A route for couples
Eugenio Santos et al.
SCIENCE SIGNALING (2018)
Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells
Elodie M. Kuntz et al.
NATURE MEDICINE (2017)
Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia
Meenu Kesarwani et al.
NATURE MEDICINE (2017)
Smart applications of bionanosensors for BCR/ABL fusion gene detection in leukemia
Karen Y. P. S. Avelino et al.
JOURNAL OF KING SAUD UNIVERSITY SCIENCE (2017)
Defining a Cancer Dependency Map
Aviad Tsherniak et al.
CELL (2017)
Chronic Myeloid Leukemia - Prognostic Value of Mutations
Bushra Kaleem et al.
Asian Pacific Journal of Cancer Prevention (2016)
The genomic landscape of core-binding factor acute myeloid leukemias
Zachary J. Faber et al.
NATURE GENETICS (2016)
Sos1 disruption impairs cellular proliferation and viability through an increase in mitochondrial oxidative stress in primary MEFs
P. Liceras-Boillos et al.
ONCOGENE (2016)
Characteristics and survival of BCR/ABL negative chronic myeloid leukemia: a retrospective analysis of the Surveillance, Epidemiology and End Results database
Smith Giri et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2015)
CD117 (c-kit) Expressiwn on CD34+Cells Participates in the Cytogenetic Response to Imatinib in Patients with Chronic Myeloid Leukemia in the First Chronic Phase
Jaroslaw Dybko et al.
ACTA HAEMATOLOGICA (2014)
Functional Redundancy of Sos1 and Sos2 for Lymphopoiesis and Organismal Homeostasis and Survival
Fernando C. Baltanas et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Leukemic spleen cells are more potent than bone marrow-derived cells in a transgenic mouse model of CML
M. Schemionek et al.
LEUKEMIA (2012)
Sos-mediated cross-activation of wild-type Ras by oncogenic Ras is essential for tumorigenesis
Hao-Hsuan Jeng et al.
NATURE COMMUNICATIONS (2012)
Rac GTPases as key regulators of p210-BCR-ABL-dependent leukemogenesis
E. K. Thomas et al.
LEUKEMIA (2008)
Rac guanosine triphosphatases represent integrating molecular therapeutic targets for BCR-ABL-induced myeloproliferative disease
Emily K. Thomas et al.
CANCER CELL (2007)
Laser microdissection and microarray analysis of the hippocampus of Ras-Grf1 knockout mice reveals gene expression changes affecting signal transduction pathways related to memory and learning
A. Fernandez-Medarde et al.
NEUROSCIENCE (2007)
Characterization of p87C3G, a novel, truncated C3G isoform that is overexpressed in chronic myeloid leukemia and interacts with Bcr-Abl
J Gutiérrez-Berzal et al.
EXPERIMENTAL CELL RESEARCH (2006)
Generation of rac3 null mutant mice:: Role of Rac3 in Bcr/Abl-caused lymphoblastic leukemia
YJ Cho et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Abl-dependent tyrosine phosphorylation of Sos-1 mediates growth-factor-induced Rac activation
P Sini et al.
NATURE CELL BIOLOGY (2004)
C3G-mediated suppression of oncogene-induced focus formation in fibroblasts involves inhibition of ERK activation, cyclin A expression and alterations of anchorage-independent growth
C Guerrero et al.
ONCOGENE (2004)
Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice
SC Kogan et al.
BLOOD (2002)
Model mice for BCR/ABL-positive leukemias
H Honda et al.
BLOOD CELLS MOLECULES AND DISEASES (2001)
Ras-guanine nucleotide exchange factor Sos2 is dispensable for mouse growth and development
LM Esteban et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
The Sos1 and Sos2 Ras-specific exchange factors: differences in placental expression and signaling properties
XL Qian et al.
EMBO JOURNAL (2000)
Share Paper
